fbpx
Medical Innovation Exchange

IN-ACTIV: NRx tanks as peptide fails NIH trial in severe COVID-19 patients

https://www.fiercebiotech.com/biotech/activ-nrx-tanks-peptide-fails-nih-trial-severe-covid-19-patients

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.